Glen Eagle Advisors, LLC Bio N Tech Se Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 100 shares of BNTX stock, worth $12,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$12,340% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$1.02 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$591 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$540 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$361 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$234 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...